Cannabis Law Report

JULY 26, 2021

SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110. In addition, SciSparc had established its supply chain infrastructure for the manufacturing and delivering of the SCI-110 drug. TEL AVIV, Israel , July 26, 2021 /PRNewswire/ — SciSparc Ltd.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105

Cannabis Law Report

SEPTEMBER 9, 2021

Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. Supply Chain Analysis. have gone a step further and legalized the recreational use of cannabis.

Recreational 95

Recreational Hemp THC Legalization 95

Cannabis Law Report

MARCH 6, 2020

KLS-13019 is Kannalife’s leading proprietary, investigational, novel, monotherapeutic product for the potential treatment of a range of neurodegenerative and neuropathic pain disorders, beginning with chemotherapy-induced peripheral neuropathy (CIPN). This is the sixth patent grant that Kannalife has received. About KLS-13019.

Research and Development 59

Research and Development Marijuana Pharmaceutical Supply Chain 59

CannaTech

JUNE 30, 2019

Patients over the age of 18 (excepting children with severe epilepsy). Neurological indications such as epilepsy, Parkinson’s. Severe epilepsy in minors. One of the main challenges to the supply chain has been the closure of a major grower holding upwards of 40% of Israeli medical cannabis licenses.

Patients 90

Patients Oil Epilepsy Strains 90

CannaTech

JUNE 30, 2019

Patients over the age of 18 (excepting children with severe epilepsy). Neurological indications such as epilepsy, Parkinson’s. Severe epilepsy in minors. The Israeli Medical Cannabis Supply Gap. Furthermore, specific strains targeting conditions including refractory epilepsy have been available in the interim.

Patients 40

Patients Oil Epilepsy Strains 40

Cannabis Law Report

JULY 15, 2022

Federal Member for Fairfax Ted O’Brien said strict controls of the supply chain would be critical to the Government’s aspirations to make Australia the number one world player in medicinal cannabis. But bottlenecks remain to doctors prescribing the controversial treatment. JOURNALIST: So is that this year?

Medicine 52

Medicine Patients Media Supply Chain 52

Cannabis Law Report

JUNE 8, 2021

Currently, the development of effective drugs based on CBD for the treatment of Alzheimer’s disease, dementia, diabetes, and epilepsy is underway. External use allows the production of creams and cosmetics for skin care, balms for muscles and joints treatment, cosmetics for bathing, hair care products.

Research and Development 98

Research and Development CBD Environment Supply Chain 98

Cannabis Law Report

NOVEMBER 22, 2019

California regulators temporarily suspended the licenses of over 400 cannabis businesses (or roughly 5 percent of the state’s legal cannabis supply chain) until those businesses implement track-and-trace system training and credentialing. Also, new cards will be good for two years, twice their current life span.

Vaping 45

Vaping Research and Development Seed-To-Sale Hemp 45

Cannabis Law Report

SEPTEMBER 12, 2019

As the court explained, the 2016 constitutional amendment requiring the creation of Florida’s medical marijuana program did not require that a MMTC control every element of the supply chain—it defined a MMTC as an entity engaging in one or more of a series of medical marijuana-related activities, not all of them.

Seed-To-Sale 65

Seed-To-Sale Supply Chain Business Programs 65

NewsMunchies

SEPTEMBER 5, 2018

A new marijuana-derived drug to treat rare forms of severe epilepsy in children will cost about $32,500 per patient, per year. supply chain, once rescheduling is complete.”. Marijuana – it’s a numbers game. Epidiolex , the first cannabis pharmaceutical to be approved by the U.S. Pfizer, GW Pharma, Merck & Co.,

Supply Chain 40

Supply Chain DEA Pharmaceutical Chronic Pain 40